Search research articles
Contact Us
Filters
Showing results (231-240 of 245) with videos related to
Page
of 25
Sort By:
The Lancet. Oncology
|
December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
October 1, 2016
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun, Wen-Fei Li, Nian-Yong Chen, et al.
BMC Medicine
|
November 28, 2023
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study
Ting Liu, Di Dong, Xun Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
International Journal of Cancer
|
January 8, 2019
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li, Nian-Yong Chen, Ning Zhang, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 245) with videos related to
Sort By:
Page
of 25
The Lancet. Oncology
|
December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
Yu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
Lei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
October 1, 2016
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun, Wen-Fei Li, Nian-Yong Chen, et al.
BMC Medicine
|
November 28, 2023
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study
Ting Liu, Di Dong, Xun Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
International Journal of Cancer
|
January 8, 2019
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li, Nian-Yong Chen, Ning Zhang, et al.
Page
of 25